Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.20.1
Equity (Tables)
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Schedule of stock options outstanding

Options Outstanding     Options Exercisable  
Range of
Exercise Price
    Number Outstanding at March 31, 2020     Range of Weighted Average Remaining Contractual Life (Years)     Weighted Average Exercise Price     Number Exercisable at March 31, 2020     Weighted Average Exercise Price  
$ 0.50       2,000,000       6.86     $ 0.50       2,000,000     $ 0.50  
  1.00 – 1.93       2,030,000       0.59 – 9.89       1.43       855,833       1.29  
  2.00 – 2.80       2,740,000       2.08 – 3.76       2.17       2,650,000       2.16  
  4.76       30,000       4.01       4.76       30,000       4.76  
$ 0.50 – 4.76       6,800,000       5.49     $ 1.47       5,535,833     $ 1.44  

Schedule of stock option activities

    Number of Options     Weighted Average Exercise Price  
Outstanding at January 1, 2020     5,260,000     $ 1.45  
Granted     1,540,000       1.53  
Terminated / Exercised     -       -  
Outstanding at March 31, 2020     6,800,000     $ 1.47  
Options exercisable at March 31, 2020     5,535,833     $ 1.44  
Options expected to vest     1,264,167     $ 1.60  

Schedule of fair value of the options using the Black-Scholes option-pricing model

    Number of Options     Weighted Average Exercise Price  
Nonvested at January 1, 2020     264,723     $ 2.00  
Granted     1,540,000       1.53  
Vested     (540,556 )     (1.59 )
Nonvested at March 31, 2020     1,264,167     $ 1.60